ARS Pharmaceuticals Inc

NASDAQ: SPRY
$9.03
-$0.07 (-0.8%)
Closing price May 17, 2024

SPRY Chart and Intraday Price

SPRY Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 500 FAIRVIEW AVENUE NORTH, SUITE 600, SEATTLE, WA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 836.14M USD
Shares Outstanding 95,997,000
ARS Pharmaceuticals Inc is a biopharmaceutical firm based in San Diego, California, focused on innovating allergy care. Founded in 2015, it's pioneering 'neffy,' a needle-free, intranasal epinephrine spray designed to offer a quick, easy-to-use emergency treatment for severe allergic reactions, including anaphylaxis. This breakthrough aims to empower patients and caregivers by providing a more accessible alternative to traditional methods.

SPRY Articles

Huge Insider Buying From Buffett, an NFL Team Owner, a New CEO
Warren Buffett boosts his stake in this tracking stock again, plus notable insider buying from an NFL team owner and a new CEO.
Trey Thoelcke
Published: